Peripheral Artery Disease

Peripheral artery disease (PAD) involves atherosclerosis mainly in the extremities, especially in the legs and feet that lead to ischemia. Untreated, PAD can progress to critical limb ischemia (CLI), also called chronic limb-threatening ischemia (CLTI), which will lead to foot or leg amputation. The mortality rate for these CLI amputees is 70% within three years. There is currently an epidemic of PAD and CLI in the U.S. The majority of patients are defined by health disparities concentrated in the Black, Latino, Native American populations in both rural and low-income urban areas. A large number of PAD patients have other comorbities, with diabetes being one a primary issue.

RSS icon

Rivaroxaban limits adverse limb and cardiovascular events in surgically treated PAD patients

Rivaroxaban was associated with more bleeding than a placebo, researchers observed, but the overall incidence of such events was still low.

amputation amputee diabetes

Bill would bolster coverage of interventional radiology services to help Americans avoid amputations

Lawmakers recently introduced the Amputation Reduction and Compassion Act in the House, with bipartisan backing and support from the Society of Interventional Radiology. 

M&A mergers and acquisitions business deal

Endologix acquires medical device company focused on peripheral artery disease

PQ Bypass, the company Endologix acquired, has gained significant attention for its Detour platform, an investigational treatment for percutaneous femoral-popliteal bypass.

Championing Alternative PAD Access in the Office-based Lab

Sponsored by Terumo

Improving access is at the center of a pair of new trends in treating peripheral artery disease (PAD). First is the office-based lab (OBL) expanding access to more PAD patients needing therapy, and the second is physicians more often choosing alternative access such as radial, tibial or pedal to treat those patients. Why now?

Boston Scientific gains FDA approval for Ranger drug-coated balloon

The newly approved solution was designed for the treatment of patients with PAD in the superficial femoral artery and proximal popliteal artery.

Thumbnail

Advocates applaud legislation that would improve coverage for peripheral artery disease screening

If signed into law, the bill would improve coverage for screening for both Medicare and Medicaid beneficiaries. 

peripheral vascular philips

Philips to acquire interventional device firm Intact Vascular for more than $275M

Around since 2011 and based in Wayne, Pennsylvania, the company specializes in treating peripheral artery disease.  

Thumbnail

'A missed opportunity': Statin use low among patients with peripheral artery disease

Researchers tracked statin use among patients with peripheral artery disease, cerebrovascular disease and coronary heart disease.

Displaying 49 - 56 of 65
Design by Adaptive Theme